Evaluating Quebec's Red-Cross Intervention
Seniors Waiting for Medico-social Care at the CIUSSS-Centre-Sud de l'île de Montréal's Territory Waiting List (GACO) : Evaluation of the Intervention of a New Partner - Quebec's Red-Cross
1 other identifier
interventional
300
1 country
1
Brief Summary
With the COVID-19 pandemic, elderly people (EP) living at home have seen their health deteriorated, thus increasing their needs in support and care. Indeed, while it was estimated that before the pandemic120 000 unattended living at home EP required care and services (taking bath, access to medication and food, etc.), the number doubled after COVID-19. Therefore, the waiting list for socio-medical services for unattended vulnerable clientele without a family doctor grew from 1300 to 1715 EP in a couple of months during the pandemic. With these numbers, it becomes clear that an intervention is needed. Truly, the Institut National d'Excellence en Santé et Services Sociaux (INESSS) concludes that it was pivotal to first identify the most vulnerable EP and second re-orient them according to their needs. Thus the principal investigator developed the Évaluation et orientation SOcio-GÉRiatrique (ESOGER) questionnaire available on a secure digital platform enabling both a rapid evaluation and intervention to asses EP needs and provide the adequate ressources. The principal investigator's previous research has demonstrated that ESOGER is one of the rare clinical tools of first contact in telehealth while being global, multidimensional, and equitable. Hence, the principal investigator hypothesizes that ESOGER is a clinical tool enabling first line care by the Red-Cross to vulnerable EP without a family doctor, which will lead to an improvement in their health, autonomy and quality of life. Moreover, the principal investigator also hypothesizes that for a better deployment, the tool needs to be adapted to Red-Cross' need and EP service providers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 28, 2021
CompletedFirst Submitted
Initial submission to the registry
September 20, 2021
CompletedFirst Posted
Study publicly available on registry
October 29, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 27, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 27, 2022
CompletedApril 10, 2024
April 1, 2024
1.1 years
September 20, 2021
April 9, 2024
Conditions
Outcome Measures
Primary Outcomes (6)
COVID-19 symptoms assessed through a questionnaire
presence or not of fever, cough, and shortness of breath (binary question)
3 months
psychological fraility
Anxiety verbal analogic scale, score from 0= no anxiety to 10= extremly anxious
3 months
Social health measured through a questionnaire
Issues related to medication and food delivery and access to home care. Presence or not of a shortage in food, medication and home care ( binary question)
3 months
Socio-economic characteristics
Presence or not of socio-economic problems (binary questions)
3 months
Participant's Quality of life
Measured by the EQ-5D scale with two parts, scale 1 score from 1= no problem to 5 ( sever health problems) and scale 2 visual analogic scale score from 0= worst possible health to 100= best possible health.
3 months
Autonomy
ADL scale score from 0= very dependent to 6= very independent and IADL scale score 0= not autonomous 4= autonomous.
3 months
Secondary Outcomes (1)
Caregiver burden
3 months
Study Arms (2)
Group intervention - questionnaire and recommendations
EXPERIMENTALThe intervention group will take the ESOGER questionnaire at month 0 and month 3 ( beginning and end) and receive recommendations following their needs.
Group control - questionnaire without recommendations
NO INTERVENTIONThe participants will only take the ESOGER questionnaire at month 0 and month 3 without recommendations.
Interventions
Resources recommendations and interventions curated to the needs of the EP such as refering them to a social activity for socially isolated EP.
Eligibility Criteria
You may qualify if:
- Aged 65 and more
- Living at home
- Be registered at the waiting list of GACO at the CIUSSS-Centre-Sud de l'île-de-Montréal (CCSMTL)
You may not qualify if:
- Principal address outside of the CCSMTL territory
- Participate at another clinical trial, to avoid interferences
- Not understand written or spoken French or English, questionnaires are only available in French and English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CRIUGM
Montreal, Quebec, H3W 1W5, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD, Senior researcher, Director of laboratory
Study Record Dates
First Submitted
September 20, 2021
First Posted
October 29, 2021
Study Start
June 28, 2021
Primary Completion
July 27, 2022
Study Completion
July 27, 2022
Last Updated
April 10, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share